Viewing Study NCT05010005

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 3:28 AM
Ignite Modification Date: 2026-02-01 @ 8:51 AM
Study NCT ID: NCT05010005
Status: RECRUITING
Last Update Posted: 2025-12-03
First Post: 2021-08-12
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Study of Ruxolitinib and Duvelisib in People With Lymphoma
Sponsor: Memorial Sloan Kettering Cancer Center
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None T-cell Lymphomas View
None NK-Cell Lymphomas View
None T-cell Prolymphocytic Leukemia View
None T-cell Large Granular Lymphocyte Leukemia View
Keywords:

Keywords

Keyword Brief Keyword Text View
None mature T-cell lymphomas View
None Ruxolitinib View
None Duvelisib View
None Relapsed or Refractory View
None 21-176 View
None T-cell Large Granular Lymphocyte Leukemia View
None T-cell Prolymphocytic Leukemia View